Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.68%
1,084.12
-7.39
-0.68%
1,091.511,090.401,090.401,081.97
SIXC
Communications
SIXC
Communications
SIXC
-0.01%
610.06
-0.050
-0.01%
610.11610.11610.29606.17
SIXE
Energy
SIXE
Energy
SIXE
+0.07%
1,238.85
+0.87
+0.07%
1,237.981,237.831,245.341,225.03
SIXI
Industrials
SIXI
Industrials
SIXI
-0.24%
1,740.35
-4.36
-0.24%
1,744.711,740.951,747.291,735.64
SIXM
Financials
SIXM
Financials
SIXM
+0.02%
640.32
+0.14
+0.02%
640.18639.92643.19636.70
SIXR
Staples
SIXR
Staples
SIXR
-0.12%
848.60
-0.98
-0.12%
849.58845.27851.68841.28
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.14%
217.78
+0.31
+0.14%
217.48217.48218.16216.39
SIXT
Technology
SIXT
Technology
SIXT
+0.59%
3,279.96
+19.27
+0.59%
3,260.693,273.363,287.813,269.07
SIXU
Utilities
SIXU
Utilities
SIXU
+0.34%
945.64
+3.19
+0.34%
942.45939.39948.80934.04
SIXV
Health care
SIXV
Health care
SIXV
-0.25%
1,463.19
-3.61
-0.25%
1,466.801,464.701,467.191,458.68
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.29%
2,404.46
+6.96
+0.29%
2,397.502,395.032,412.012,391.98
Q1 2026 earnings • in 2 days
See details
TSHA:NASDAQ
Taysha Gene Therapies Inc
$6.60
+4.34%
(+0.28) 1D
May 4, 11:20:34 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TSHA...
Open
$6.33
High
$6.64
Low
$6.28
Mkt. cap
1.87B
Volume
407.96K
52-wk high
$6.76
52-wk low
$1.85
EPS
-$0.34
Beta
1.25
Shares outstanding
287.34M
No. of employees
99
News stories
From sources across the web
About Taysha Gene Therapies Inc
CEO-
Employees99
Founded2019
HeadquartersDallas, Texas, United States
SectorBiotechnology
Next call in 45:07:17
Wed, May 6, 8:30 AM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-0.10 est.)USD
Revenue / Estimate
-/ (758.33K est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.30M
1.99M
-
5.48M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15.56M
20.14M
25.74M
24.95M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.16M
8.60M
8.28M
8.83M
Operating expense
23.72M
28.74M
34.02M
33.78M
Total operating expenses
23.72M
28.74M
34.02M
33.78M
Operating income
-21.42M
-26.75M
-34.02M
-28.30M
Other non operating income
115.00K
-510.00K
-1.86M
3.76M
EBT including unusual items
-21.53M
-26.88M
-32.73M
-27.85M
EBT excluding unusual items
-20.00M
-25.42M
-32.73M
-21.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21.53M
-26.88M
-32.73M
-27.85M
Net profit margin
-935.23%
-1,353.58%
-
-507.77%
Earnings per share
-0.07
-0.08
-0.09
-0.07
Interest and investment income
1.33M
1.86M
3.17M
2.87M
Interest expense
-19.00K
-17.00K
-15.00K
-12.00K
Net interest expenses
1.31M
1.84M
3.15M
2.86M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.14M
-26.48M
-33.74M
-28.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more